Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-009361
Filing Date
2023-04-05
Accepted
2023-04-04 18:08:54
Documents
27

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A zvra20230404_defa14a.htm DEFA14A 31484
2 i1.jpg GRAPHIC 59777
3 i2.jpg GRAPHIC 102899
4 i3.jpg GRAPHIC 66351
5 i4.jpg GRAPHIC 73571
6 i5.jpg GRAPHIC 42642
7 i6.jpg GRAPHIC 69429
8 i7.jpg GRAPHIC 48712
9 i8.jpg GRAPHIC 70224
10 i9.jpg GRAPHIC 67217
11 i10.jpg GRAPHIC 63111
12 i11.jpg GRAPHIC 88773
13 i12.jpg GRAPHIC 56198
14 i13.jpg GRAPHIC 61718
15 i14.jpg GRAPHIC 63834
16 i15.jpg GRAPHIC 74943
17 i16.jpg GRAPHIC 74256
18 i17.jpg GRAPHIC 25630
19 i18.jpg GRAPHIC 45600
20 i19.jpg GRAPHIC 65431
21 i20.jpg GRAPHIC 62530
22 i21.jpg GRAPHIC 31451
23 i22.jpg GRAPHIC 76128
24 i23.jpg GRAPHIC 87593
25 i24.jpg GRAPHIC 87360
26 i25.jpg GRAPHIC 57068
27 i26.jpg GRAPHIC 50948
  Complete submission text file 0001437749-23-009361.txt   2339751
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 23800033
SIC: 2834 Pharmaceutical Preparations